Abstract
A sample of the human cDNA was used to amplify the segment encoding biosynthesis of chymotrypsin-like protease of kallikrein-7 and its cloning into the expressing plasmid pET23a(+). Biosynthesis of KLK-7 in transformed E. coil BL21(DE3) cells was accompanied by formation of insoluble inclusion bodies. The recombinant KLK-7 was extracted from the inclusion bodies using 7 M urea in the presence of 2-mercaptoethanol. The extracted recombinant KLK-7 was purified using methods of metal-chelate and ion-exchange chromatography, converted into a soluble form, and used for preparing monospecific antiserum.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / immunology
-
Chromatography, Liquid
-
Cloning, Molecular
-
Escherichia coli* / genetics
-
Escherichia coli* / metabolism
-
Gene Expression*
-
Humans
-
Inclusion Bodies / genetics
-
Inclusion Bodies / immunology
-
Inclusion Bodies / metabolism
-
Kallikreins / biosynthesis*
-
Kallikreins / genetics
-
Kallikreins / immunology
-
Kallikreins / isolation & purification
-
Plasmids / genetics
-
Recombinant Proteins / biosynthesis*
-
Recombinant Proteins / genetics
-
Recombinant Proteins / immunology
-
Recombinant Proteins / isolation & purification
Substances
-
Antibodies, Monoclonal
-
Recombinant Proteins
-
KLK7 protein, human
-
Kallikreins